Managing director Dr Richard Lipscombe showcased the company and PromarkerD, the world leading predictive diagnostic test for diabetic kidney disease, at Investor Briefings as part of Proactive’s CEO Spotlight Investor Session in Melbourne (11th April) and Sydney (12th April).170407-PIQ-Corporate-presentation-Proactive-170407PIRL
Investor presentation: Global leader in applying proteomics to MedTech